Affinity Reagent News and Research

RSS

Using synthetic peptides for inflammatory disease diagnosis

Scientists have developed a peptide that binds to the protein calprotectin, a marker of major inflammatory disorders, and shown that it is suitable for diagnostic tests.

17 May 2023

Lateral flow assays: The possibilities beyond COVID-19

In this interview, News-Medical talks to Andre Alfaro from nanoComposix (now a Fortis Life Sciences company) about the possibilities lateral flow assays offer in the post-covid healthscape.

From nanoComposix 17 Mar 2022

MIP Diagnostics secures £7.3M investment following achievement of critical milestones

Mercia Asset Management, Calculus Capital, Downing Ventures and BGF scale joint investment in latest fundraise.

From MIP Discovery 1 Mar 2022

MIP Diagnostics to support the development of challenging affinity reagents with new Molecular Imprinting Epitope Discovery

MIP Diagnostics has today announced the launch of its novel Molecular Imprinting Epitope Discovery Service.

26 Oct 2021

DNA synbodies, a new class of affinity reagents, gets major NIH boost

An ongoing Arizona State University effort to develop a revolutionary class of reagents that holds great promise for the future of medicine has received a major boost with a three-year, $4 million award from the National Institutes of Health.

24 Oct 2011

Affinity Reagent News and Research

Using synthetic peptides for inflammatory disease diagnosis

Lateral flow assays: The possibilities beyond COVID-19

MIP Diagnostics secures £7.3M investment following achievement of critical milestones

MIP Diagnostics to support the development of challenging affinity reagents with new Molecular Imprinting Epitope Discovery

DNA synbodies, a new class of affinity reagents, gets major NIH boost

Innovations in baculovirus–insect cell expression systems

Compound Management and its Crucial Role in Early Pharmaceutical Research

Natural products: the next frontier in drug discovery

Latest News